Skip to content

Chemed CHE Deferred Tax Liabilities Right Of Use Lease Assets

Deferred Tax Liabilities Right Of Use Lease Assets at other companies

AZZ logo
AZZAZZ
$14.62M+135%
JAN
Janus Living JAN
$33K
Moelis & Company logo
Moelis & CompanyMC
$49.74M+21.3%
Flagstar Bank
 logo
Flagstar Bank FLG
$101M-7.3%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$7.92M-14.3%
Corvex
 logo
Corvex MOVE
$91K-12.5%

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept che:DeferredTaxLiabilitiesRightOfUseLeaseAssets.

The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's deferred tax liabilities right of use lease assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's deferred tax liabilities right of use lease assets?
Chemed (CHE) reported deferred tax liabilities right of use lease assets of $31.54M in Q4 2025.
How has Chemed's deferred tax liabilities right of use lease assets changed year-over-year?
Chemed's deferred tax liabilities right of use lease assets increased by 2.8% year-over-year, from $30.68M to $31.54M.
What is the long-term trend for Chemed's deferred tax liabilities right of use lease assets?
Over 5 years (2020 to 2025), Chemed's deferred tax liabilities right of use lease assets has grown at a -0.1% compound annual growth rate (CAGR), from $31.69M to $31.54M.
What does deferred tax liabilities right of use lease assets mean?
This represents the deferred tax liability arising from the temporary difference between the book value of right-of-use lease assets and their tax basis. It reflects the future tax consequences of accounting for operating leases under current lease standards versus tax reporting requirements. Monitoring this helps investors understand the timing of tax payments related to long-term lease obligations.